Sanara MedTech Analyst Ratings
Sanara MedTech Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/15/2023 | 50.77% | Cantor Fitzgerald | $59 → $49 | Maintains | Overweight |
09/26/2023 | 81.54% | Cantor Fitzgerald | → $59 | Reiterates | Overweight → Overweight |
08/22/2023 | 81.54% | Cantor Fitzgerald | → $59 | Reiterates | Overweight → Overweight |
08/17/2023 | 81.54% | Cantor Fitzgerald | → $59 | Reiterates | Overweight → Overweight |
06/30/2021 | 38.46% | Cantor Fitzgerald | → $45 | Initiates Coverage On | → Overweight |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
11/15/2023 | 50.77% | 坎託·菲茨傑拉德 | 59 美元 → 49 美元 | 維護 | 超重 |
09/26/2023 | 81.54% | 坎託·菲茨傑拉德 | → 59 美元 | 重申 | 超重 → 超重 |
08/22/2023 | 81.54% | 坎託·菲茨傑拉德 | → 59 美元 | 重申 | 超重 → 超重 |
08/17/2023 | 81.54% | 坎託·菲茨傑拉德 | → 59 美元 | 重申 | 超重 → 超重 |
2021 年 6 月 30 日 | 38.46% | 坎託·菲茨傑拉德 | → 45 美元 | 啓動覆蓋範圍開啓 | → 超重 |
What is the target price for Sanara MedTech (SMTI)?
Sanara MedTech(SMTI)的目標價格是多少?
The latest price target for Sanara MedTech (NASDAQ: SMTI) was reported by Cantor Fitzgerald on November 15, 2023. The analyst firm set a price target for $49.00 expecting SMTI to rise to within 12 months (a possible 50.77% upside). 4 analyst firms have reported ratings in the last year.
坎託·菲茨傑拉德於2023年11月15日公佈了Sanara MedTech(納斯達克股票代碼:SMTI)的最新目標股價。該分析公司將目標股價定爲49.00美元,預計SMTI將在12個月內升至12個月內(可能上漲50.77%)。去年有4家分析公司公佈了評級。
What is the most recent analyst rating for Sanara MedTech (SMTI)?
Sanara MedTech(SMTI)的最新分析師評級是多少?
The latest analyst rating for Sanara MedTech (NASDAQ: SMTI) was provided by Cantor Fitzgerald, and Sanara MedTech maintained their overweight rating.
坎託·菲茨傑拉德對Sanara MedTech(納斯達克股票代碼:SMTI)的最新分析師評級由坎託·菲茨傑拉德提供,Sanara MedTech維持增持評級。
When is the next analyst rating going to be posted or updated for Sanara MedTech (SMTI)?
Sanara MedTech(SMTI)的下一次分析師評級何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sanara MedTech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sanara MedTech was filed on November 15, 2023 so you should expect the next rating to be made available sometime around November 15, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與Sanara MedTech的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級,因此每家公司每年應該獲得4次評級。Sanara MedTech的最新評級是在2023年11月15日公佈的,因此您應該預計下一個評級將在2024年11月15日左右公佈。
Is the Analyst Rating Sanara MedTech (SMTI) correct?
分析師對Sanara MedTech(SMTI)的評級是否正確?
While ratings are subjective and will change, the latest Sanara MedTech (SMTI) rating was a maintained with a price target of $59.00 to $49.00. The current price Sanara MedTech (SMTI) is trading at is $32.50, which is out of the analyst's predicted range.
儘管評級是主觀的,並且會發生變化,但最新的Sanara MedTech(SMTI)評級保持不變,目標股價爲59.00美元至49.00美元。Sanara MedTech(SMTI)目前的交易價格爲32.50美元,超出了分析師的預期區間。